You should read the following management discussion and analysis ("MD&A") together with the risk factors set forth in Item 1A and with our audited Consolidated Financial Statements and Notes thereto included elsewhere herein.





Overview


Applied Energetics, Inc., specializes in the development and manufacture of advanced high-performance lasers and optical systems, high voltage electronics, and integrated guided energy systems for prospective defense, national security, industrial, biomedical, and scientific customers worldwide.

Gregory J. Quarles serves as our President and Chief Executive officer and, pursuant to a consulting agreement with an LLC wholly owned by him, Dr. Stephen W. McCahon serves as our Chief Scientist. AE has continued to expand its technical capabilities with the addition of employees, consultants and contractors, and agreements with several of the leading laser and optics universities in the country. The team at Applied Energetics continued to expand during 2022 and into early 2023, with the addition of nine new employees, including its Chief Operating and Financial Officer, one junior and one midlevel scientist, two laser technicians, a part-time senior product development advisor, an engineering project manager, in-house counsel, a finance manager and an executive assistant. AE also works with a team of world-class contractors to strengthen our human resources, compliance, public relations, IT, and technical staff supporting the research and development in the laboratory.





                                       16




AE owns and protects intellectual property that is integral and necessary for the development of Ultrashort Pulse ("USP™") Lasers, Laser Guided Energy ("LGE®") and Direct Discharge Electrical products for military and commercial applications. AE currently owns 27 patents and an additional 11 Government Sensitive Patent Applications ("GSPA"). These GSPA's are held under secrecy orders of the US government and allow the company greatly extended protection rights, including having no expiration date until such time as they are no longer classified after which they will have the normal 20-year patent protection. The company also has seven pending patent applications and one provisional patent application which is undergoing conversion to its non-provisional form. We continue to file patent applications as we deem appropriate to protect our intellectual property and enhance our competitive advantage.

During the year ended December 31, 2022, our business development efforts began to come to fruition as AE was awarded a research grant by the U.S. Marine Corps and a Phase I STTR contract by the U.S. Army. In May 2022, Applied Energetics was awarded a $3.89 million, two-year grant from the Department of the Navy, Office of Naval Research (ONR), to develop an optical system capable of defeating customer-specified threats for integration onto U.S. Marine Corps (USMC) platforms. We were awarded this grant to accelerate the development and testing of Infrared (IR) optical technology with an ultrashort pulse laser (USPL) system. The overall objective is to advance and ruggedize optical technologies that can be fielded on a variety of USMC platforms and are able to operate in harsh conditions.

We also executed a Phase I Small Business Technology Transfer (STTR) contract with the U.S. Army on June 2, 2022. The objective of the contract was the delivery of an ultra-broadband infrared (IR) source. Under this contract, Applied Energetics, modeled novel approaches for the eye-safe delivery of ultra-broadband infrared laser pulses to electro-optic sensors. Electro-Optical/Infrared (EO/IR) sensors are imaging systems used for military applications. The STTR program is a federally funded initiative to incorporate small business technological innovation into government supported research and development programs. STTRs require the small business to team with a university or non-profit and are structured in three potential phases. Applied Energetics proposed to partner with the James C. Wyant College of Optical Sciences at the University of Arizona for Phase I.

We began work on each of these projects and completed the last deliverable under the STTR contract during the year. We anticipate producing all deliverables required under the grant in a successful and timely manner.

Prior to receiving the above-described grant and contract, we had experienced delays in responses to multiple proposals we had submitted to government agencies due to the Covid-19 related closures of these agencies and work-from-home orders across various regions of the United States, as resources were focused on other matters within the government. Since the reopening of proposal reviews and processing, AE's team has been invited to, and completed, multiple briefings focused on our capabilities and our submissions. However, this positive action by the agencies could be reversed as Covid remains an ongoing risk. Any changes to reinstate the closures or work-from-home orders could again hamper the ability of the AE team to schedule on-site briefings for our proposals undergoing review.

In addition to these review-based delays, the US federal budgets for both 2022 and 2023 were not approved by Congress by the start of the U.S. federal government fiscal year, which is October 1 of the preceding year. In September of 2021 and 2022, Congress passed, and the president signed, continuing resolutions ("CRs"), to extend federal government funding through December 3, 2021, and December 16, 2022, respectively. On December 2, 2021, a second CR was signed into law, extending funded operations through February 18, 2022, and then a third CR was signed on February 17, 2022, extending funding through March 11, 2022. The final appropriations bill was signed into law by President Biden on the night of March 11, 2022. Similarly, on December 16, 2022, a second CR for fiscal 2023 was signed into law, extending funding through December 23, 2022, and on December 22, 2022, a third CR was signed into law, extending funding through December 30, 2022. The final appropriations bill was signed into law on December 29, 2022 and, as in the prior year's bill, includes increases in areas of particular interest to the company. However, the delays and uncertainty around funding may delay allocation of funds or pose a payment risk for the company under any grants or agreements under which we are already working.





Strategic Plan and Analysis


We plan to continue building our management team with highly qualified individuals. We intend to recruit additional personnel in the areas of R&D, science and simulation, marketing and finance, and, possibly add members to our Board of Directors and our Board of Advisors. We have worked to align key innovations with our roadmap to encourage and enable internal filing for a broad, strategic and robust intellectual property portfolio and continue surveying the literature for acquisitions of parallel intellectual property to that end. We also intend to pursue strategic corporate acquisitions in related fields and technology. We continue to explore any favorable equity financing opportunities.





                                       17




Our goal with the Applied Energetics Strategic Plan is to increase the energy, peak power and frequency agility of USP optical sources while decreasing the size, weight, and cost of these systems. We are in the process of developing this breadth of very high peak power USP lasers and additional optical sources that have a very broad range of applicability for threat disruption for the Department of Defense, commercial, and biomedical applications such as biophotonic illumination and imaging. Although the historical market for Applied Energetics' LGE and USP technology is the U.S. Government, the USP technologies are expected to provide numerous platforms for commercial additive and subtractive manufacturing and biomedical and imaging markets, creating a substantially larger market for our products to address. Since 2020, the Applied Energetics team was able to develop partnership and teaming arrangements with the three leading laser and optics institutes in the United States, namely, the University of Arizona, the University of Central Florida, and the University of Rochester Laboratory for Laser Energetics. Our desire is to work on programs jointly where the strengths of each organization can assist in escalating knowledge and delivery of systems to the government sponsors, and to train the next generation of scientists and engineers to work in the directed energy fields.

Despite the challenges posed by COVID-19, we have continued to execute our business development plans, further our research and development program and submit filings for intellectual property and proposals for grants and contracts. During the past two fiscal years, we submitted multiple proposals and have been engaged in meetings on a daily and weekly basis with various agencies and departments both remotely and in person in Washington, DC and at various other government facilities. Having received a significant research grant and an STTR contract during the second quarter of 2022, we believe the interest in our technology and applications remains high, and we continue to submit proposals for all appropriate opportunities and share our vision of the disruptive capabilities of USP optical sources for both near- and far-term threats and dual-use commercial applications.

Through our analysis of the market, and in discussions with potential customers, we remain convinced that customers are becoming more receptive and interested in directed energy technologies. According to the US Department of Defense fiscal budgets from 2017 through 2023, its directed energy spending grew from approximately $500 million in 2017 to over $1.695 billion in 2023, an increase of nearly 240%. Market analysis and projections have estimated that this directed energy sector is anticipated to exceed $10.1 billion globally by 2026. We continue to be optimistic about our future and the growing opportunities in directed energy applications, especially since this growth to nearly $1.7 B annually is being accomplished without a recognized Program of Record (POR) for directed energy platforms. Once these technologies are funded in production for a POR, these DOD budgets for DE will grow exponentially larger to support the technology insertion. The Applied Energetics team anticipates a continuation of strong funding for the directed energy community. With our existing patent portfolio, and through further advancements of our technologies, we believe we have the substantial building blocks needed to become a significant and successful developer in our USP and LGE marketplaces.





Critical Accounting Policies



Use of Estimates


The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other inputs and estimates that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein.





Share-Based Payments


Stock-based compensation cost is measured at grant date, based on the fair value of the award and is recognized as an expense over the requisite service period.





                                       18




The fair value of each option grant is estimated at the date of grant using the Black-Scholes-Merton option valuation model. We make the following assumptions relative to this model: (i) the annual dividend yield is zero as we do not pay dividends on our common stock, (ii) the weighted-average expected life is based on a midpoint scenario, where the expected life is determined to be half of the time from grant to expiration, regardless of vesting, (iii) the risk free interest rate is based on the U.S. Treasury security rate for the expected life, and (iv) the volatility is based on the level of fluctuations in our historical share price for a period approximately equal to the weighted-average expected life. We estimate forfeitures when recognizing compensation expense and adjust this estimate over the requisite service period should actual forfeitures differ from such estimates. Changes in estimated forfeitures are recognized through a cumulative adjustment, which is recognized in the period of change and which impacts the amount of unamortized compensation expense to be recognized in future periods.





Income Taxes


Deferred tax assets and liabilities are recognized currently for the future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than not that such assets will not be realized.





Results of Operations



Our consolidated financial information for the years ending December 31, 2022
and 2021 is as follows:



                                            2022             2021
Revenue                                 $  1,307,757     $          -
Cost of revenue                              305,675                -
Gross Profit                               1,002,082                -
Operating expenses:
General and administrative                 6,129,781        4,903,081
Selling and marketing                        321,384          317,350
Research and development                     320,506          281,896
Total operating expenses                   6,771,671        5,502,327
Other income/(expenses):
Other income                                   1,674           81,218
Interest (expense)                            (3,727 )         (4,344 )
Other income/(expense)                        (2,053 )         76,874
Loss before provision of income taxes     (5,771,642 )     (5,425,453 )
Provision for income taxes                         -                -
Net loss                                $ (5,771,642 )   $ (5,425,453 )




Revenue


Revenue increased by approximately $1,308,000 to approximately $1,308,000 for the year ended December 31, 2022 from zero for the year ended December 31, 2021. Revenues for the 2022 period were from a contract and a grant that we received and commenced performing in June 2022.





Cost of Revenue


Cost of revenue increased by approximately $306,000 to approximately $306,000 for year ended December 31, 2022, from zero during the year ended December 31, 2021. This represents costs directly associated with the contract and grant that company commenced in June 2022.





General and Administrative


General and administrative expenses increased approximately $1,226,700 to $6,130,000 for the year ended December 31, 2022, compared to approximately $4,903,000 for the year ended December 31, 2021, primarily due to a decrease of approximately $24,000 in professional expenses, an increase in salaries and employee benefits of approximately $912,000, in IT costs of approximately $22,000, in depreciation expense of approximately $56,000 and in insurance of $67,000. The remaining increase of approximately $198,000 consists of office supplies, equipment rental, travel, meals and investor relations expenses.





                                       19





Selling and Marketing


Selling and Marketing expenses increased approximately $4,000 to $321,000 for the year ended December 31, 2022, compared to approximately $317,000 for the year ended December 31, 2021, primarily due to the continuation of business development activities through our Master Services Agreement with Westpark Advisors as well as the addition of other consultants in this field.





Research and Development


Research and development expenses increased approximately $39,000 to $321,000 for the year ended December 31, 2022, compared to approximately $282,000 the year ended December 31, 2021, primarily assets that were placed into service during the last two quarters of 2022 that are actively being used to generate work in progress research and development of the company core technologies.





Other Income/(Expense)


Other income decreased approximately $80,000 to $(2,000) for the year ended December 31, 2022, compared to $77,000 for the year ended December 31. 2021, primarily due to the partial forgiveness of the company's PPP loan.





Net Loss


Our operations in 2022 resulted in a net loss of approximately $5,772,000, an increase of approximately $346,500 compared to the approximately $5,425,500 net loss for 2021, primarily due to increases in general and administrative and research and development expenses, partially offset by higher revenue and a decrease in selling and marketing expense.





Trend Discussion


During the year ended December 31, 2022, as we received our ONR grant and STTR contract with the Army, we recognized revenues as we performed these services and also recorded related costs. Costs under this grant and contract were amplified by ongoing system-wide supply chain disruptions,resulting primarily from the Covid-19 pandemic, shortages of items like semiconductor chips, and related systemic issues, and general inflation. In particular, micro-electronic and semiconductor chip shortages are still impacting supply chains, and as such, can impact our ability to execute and deliver technology to meet demands of our customers. These costs and supply issues also may affect any internal research and development programs, and we anticipate that they will continue for at least the near term.

Our costs and the timing of our performance under grants and contracts are also affected by trends in the US labor market, particularly, recruiting of scientists and technicians. We are currently onboarding three new employees and expect to continue to hire in the next three quarters. We had observed some limited availability in this market, but in early 2023, this has improved, and we anticipate being able to locate and retain the necessary personnel for the foreseeable future.

Liquidity and Capital Resources





Going Concern


The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. At December 31, 2022, the company had total current assets of $6,086,231 and total current liabilities of $756,532, resulting in working capital surplus of $5,329,699. At December 31, 2022, we had $5,640,308 of cash and cash equivalents, an increase of $1,977,693 from $3,662,615 at December 31, 2021.

During the year ended December 31, 2022, the net cash outflow from operating activities was $3,929,837. This amount was comprised primarily of our net loss of $5,771,642. This was offset by non-cash stock-based compensation expense of $1,776,140, amortization of future compensation payable of $416,666, amortization of prepaid assets of $221,352, loss on disposal of equipment of $14,540, depreciation and amortization expense of $73,519, and the amortization of right of use assets of $112,613. Additionally, net cash used from changes in assets and liabilities totaled $773,025. This included an increase in accounts receivable $353,149, increase in prepaid and deposits of $270,735, a decrease in accounts payable of $78,412 and a decrease in operating lease liabilities of $76,288. This is offset by an increase in accrued expenses and compensation of $5,499.





                                       20




During the year ended December 31, 2022, the net cash outflow from investing activities was $74,184. This was for the acquisition of equipment.

During the year ended December 31, 2022, net cash flows from financing activities were $5,981,709. This amount consisted of $175,435 in proceeds on a note payable for insurance premium financing, $19,069 from the exercise of options, and $6,586,198 in proceeds from the issuance and sale of 2,993,727 shares of common stock, to investors in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended, which was offset by $798,988 in conjunction with the monthly repayment of the note for the company's insurance premium financing and AOS note. The proceeds from a subscription payable represent funding received as part of a pending private placement of equity.

On April 28, 2020, AE was awarded a loan for $132,760 through the Small Business Administration (SBA) Paycheck Protection Program (PPP). The terms of this loan were twenty-four months with a 1% annual interest rate. These funds were issued to cover payroll costs over 8 weeks of May and June 2020. Through the utilization of this PPP loan, AE was able to keep all employees fully engaged during these two months of the pandemic. Accordingly, on July 2, 2021, we received a letter from our bank, via the SBA, approving conversion of $80,593.55 of the loan to a grant. Between January and April 2022, the company fully repaid the balance of the loan in four monthly installments at the 1% annual interest rate and no amounts remain outstanding.

Based on the company's current business plan, we believe our cash balance as of the date of this report, along with anticipated revenues from our recently received ONR grant and STTR agreement, will be sufficient to meet the company's anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable.

The company's existence is dependent upon management's ability to develop profitable operations. Management is devoting a significant portion of its efforts to developing additional business and raising capital, as needed, but cannot be certain that these efforts will be successful. Management's business development efforts may not result in profitable operations. To fund its research and development and marketing efforts, the company's management continues to explore possible financing opportunities through discussions with investment bankers and private investors. The company may not be successful in its effort to secure additional financing on terms it considers favorable. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.

Additionally, the Russian military action in Ukraine and related economic sanctions around the globe could impact the company's ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company's ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company's financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Budgeting for upcoming expenses and costs of supplies and equipment needed to perform our ONR grant, described under "Recent Developments" above, and any other contracts or grants we receive in the future, requires that we estimate factors such as inflation and geo-political events that affect such expenses and costs. The cost of labor continues to increase across many sectors of the US and global economy which is likely to drive up our general and administrative expenses as well as the cost of personnel working directly and indirectly on our grants and contracts. This aspect of inflation is particularly difficult given the highly skilled nature of this work. Inflation is also likely to impact the price of supplies and materials we must purchase in order to perform grants and contracts, some of which may have been bid on based on cost structures which were submitted during periods of lower inflation. In addition, the war in Ukraine and other related geo-political events have further limited the number of countries from which we can source certain supplies and equipment. These limitations can range from outright prohibitions to strong discouragement based on potentially sensitive information. We continually monitor these events and the markets for needed supplies in order to make the best estimates possible, both in our internal budgeting and in any bids or proposals we submit.





                                       21





Contractual Obligations:


The following table summarize our contractual obligations and other commercial commitments as of December 31, 2022:





                                   Payment by Period
                     Total       Less than 1 Year       1 to 5 Years

Notes payable      $ 400,000     $         400,000     $            -
Due to affiliate      50,000                50,000                  -
Leases               507,000               143,000            364,000
Total              $ 957,000     $         593,000     $      364,000

The above table does not include the dividends on our Series A Preferred Stock. Assuming that there is no conversion of the outstanding shares of Series A Preferred Stock into shares of common stock, the dividends are approximately $34,000 each year (approximately $9,000 each quarter).





Leases:


In March 2021, the company signed a five-year lease for an 11,000 usable square foot (13,000 rentable square foot) laboratory/office space in Tucson. The lease term commences May 1, 2021 and ends on April 30, 2026. The base rent is $6.7626 per rentable square foot for year one, and escalates to $9.2009 in year two, $11.4806 in year three, $13.1740 in year four and $14.9306 in year five, plus certain operating expenses and taxes.





Preferred Stock


The Series A Preferred Stock has a liquidation preference of $25.00 per share. The Series A Preferred Stock bears dividends at an initial rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. We have not paid dividends commencing with the quarterly dividend due August 1, 2013 and, as a result, the dividend rate has increased to 10% per annum and will remain at that level until such failure is cured. Dividends due as of December 31, 2022, and March 11, 2023, were approximately $322,000 and $338,000, respectively.

The holders of the Series A Preferred Stock have a right to put the stock to the company for an aggregate amount equal to the liquidation preference (approximately $340,000) plus unpaid dividends of $331,549 as of December 31, 2022, in the event of a change in control. Dividends are payable in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement or (iii) any combination of the foregoing. As of December 31, 2022, there were 13,602 shares of Series A Preferred Stock outstanding.

Recent Accounting Pronouncements:

Refer to Note 3 of Notes to Consolidated Financial Statements for a discussion of recent accounting standards and pronouncements.

Off-Balance Sheet Arrangement:

As of December 31, 2022, we had no significant off-balance sheet arrangements.


                                       22

© Edgar Online, source Glimpses